Notes
Reactions Weekly provides rapid alerts to news on drug safety. Summarising information selected from over 1700 biomedical publications, this newsletter is produced by Adis International Limited and is available in a variety of formats. Please contact your nearest Adis office for subscription details.
References
Opatrny L, Khwaja K, Kimoff J, et al. Death related to albendazole-induced pancytopenia: case report and literature review [abstract]. 52nd Annual Meeting of the American Society of Tropical Medicine and Hygiene; 2003 Dec 3–7; Philadelphia
Lo SH-K, Wong K-S, Mo K-L. Treatment by haemodialysis in a case of adult-onset (type II) citrullinaemia in a Chinese patient with pulmonary tuberculosis. Nephrol Dial Transplant 2003 Oct; 18 (10): 2182–4.
Gaku S, Naoshi K, Teruhiko A. A case of bepridil induced interstitial pneumonitis. Heart 2003 Dec; 89 (12): 1415
Sodhi PK, Verma L, Ratan J. Dermatological side effects of brimonidine: a report of three cases. J Dermatol 2003 Sep; 30 (9): 697–700.
Polard E, Trioux E, Flet L, et al. Luclopathy induced by levodopa associated with bromocriptin. Presse Med 2003 Aug 9; 32 (26): 1223.
Ugland HG, Myhr K, Brørs O, et al. Brain stem infarction associated with bupropion. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 269
Morton A, Muir J, Lim D. Rash and acute nephritic syndrome due to candesartan. BMJ 2004 Jan 3; 328 (7430): 25.
Srairi S, El Aïdli S, Kastalli S, et al. Fixed drug eruption induced by carbocisteine. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 265
Finsterer J, Kotzailias N. Thrombocytosis under ciprofloxacin and tazobactam/piperacillin. Platelets 2003 Aug; 14 (5): 329–31.
Richards S, Umbreit JN, Fanucchi MP, et al. Selective serotonin reuptake inhibitor-induced rhabdomyolysis associated with irinotecan. South Med J 2003 Oct; 96 (10): 1031–3.
Adson DE, Kotlyar M. Premature ejaculation associated with citalopram withdrawal. Ann Pharmacother 2003 Dec; 37 (12): 1804–6.
Phillips EJ, Knowles SR, Shear NH. Serum sickness-like reaction associated with clopidogrel. Br J Clin Pharmacol 2003 Nov; 56 (5): 583
Tröger U, Lins H, Banditt P, et al. Tetraparesis in a patient with colchicine retention in the cerebrospinal fluid due to verapamil probably by inhibition of PGP efflux pump. Int J Clin Pharmacol Ther 2003 Nov; 41 (11): 555–6.
De Angelis R, Silveri F, Bugatti L, et al. Raynaud’s phenomenon after combined adjuvant chemotherapy for breast cancer. Chemotherapy 2003 Sep; 49 (5): 267–8.
Onofrj M, Thomas A. Severe worsening of parkinsonism in Lewy body dementia due to donepezil. Neurology 2003 Nov 25; 61 (10): 1452.
Mangge H, Gindl S, Kenzian H, et al. Atopic dermatitis as a side effect of anti-tumor necrosis factor-alpha therapy. J Rheumatol 2003 Nov; 30 (11): 2506–7.
Schöttker B, Dösch A, Kraemer DM. Severe hepatotoxicity after application of desloratadine and fluconazole. Acta Haematol 2003; 110 (1): 43–4.
Katz HT, Lang DM, Inamdar SR, et al. Successful desensitization to glatiramer acetate (Copaxone) in two patients with multiple sclerosis [abstract no. P156 plus poster]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov 7–12; New Orleans, 62–63
Uchida H, Suzuki T, Watanabe K, et al. Antipsychotic-induced paroxysmal perceptual alteration. Am J Psychiatry 2003 Dec; 160 (12): 2243–4.
Otte W, Birkenhager TK, van den Broek WW. Fatal interaction between tranylcypromine and imipramine. Eur Psychiatry 2003 Aug; 18 (5): 264–5.
Mabudian M, Kumar P. Unusual adverse reaction of intravenous immunoglobulin (IVIG) in patient with idiopathic thrombocytopenic purpura (ITP) [abstract no. P166 plus poster]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov7–12; New Orleans, 65
Eklund KK, Peltomaa R, Leirisalo-Repo M. Occurrence of pulmonary thromboembolism during infliximab therapy. Clin Exp Rheumatol 2003 Sep–Oct; 21 (5): 679
Tan E-K, Chan L-L, Lo Y-L. Myorhythmia slow facial tremor from chronic interferon alpha-2a usage. Neurology 2003 Nov; 61 (9): 1302–3.
Martínez-Alonso JC, Domínguez-Ortega FJ, Fuentes-Gonzalo MJ. Urticaria and angioedema due to itraconazole. Allergy 2003 Dec; 58 (12): 1317–8.
Kazama JJ, Suzuki K, Yokoseki A, et al. Development of hungry bone syndrome after rapid lowering of PTH with intravenous maxacalcitol therapy in a patients with non-uremic secondary hyperparathyroidism. Clin Nephrol 2003 Nov; 60 (5): 369–71.
Margolin L. Impaired rehabilitation secondary to muscle weakness induced by meropenem. Clin Drug Invest 2003; 24 (1): 61–2.
Fogl T, Margolese HC. Fungal dermatitis with olanzapine in schizophrenia. Can J Psychiatry 2003 Oct; 48 (9): 643–4.
Duijvestijn YCM, Kalmeijer MD, Passier ALM, et al. Neonatal intraventricular haemorrhage associated with maternal use of paroxetine. Br J Clin Pharmacol 2003 Nov; 56 (5): 581–2.
Kontaxakis VP, Havaki-Kontaxaki BJ, Pappa DA, et al. Neuroleptic malignant syndrome after addition of paroxetine to olanzapine. J Clin Psychopharmacol 2003 Dec; 23 (6): 671–2.
Cohen MA, Galbut B, Kerdel FA. Exogenous lipoid pneumonia caused by facial application of petrolatum. J Am Acad Dermatol 2003 Dec; 49 (6): 1128–30.
Bahrainwala AH. Eczema herpeticum during treatment of atopic dermatitis with pimecrolimus (Eledil, 1%) cream [abstract]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov 7–12; New Orleans, 54
Löbbe J, Stucky L, Saurat JH. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream. Dermatology 2003; 207 (2): 205–7.
Ratinahirana H, Benigni J-P, Bousser M-G. Injection of polidocanol foam (PF) in varicose veins as a trigger for attacks of migraine with visual aura. Cephalalgia 2003 Oct; 23 (8): 850–1.
Anagnostopoulos GK, Kostopoulos P, Tsiakos S, et al. Fulminant pancreatitis associated with ramipril therapy. Pancreas 2003 Oct; 27 (3): 278–9.
Goyal RS, Goyal SB. Symptomatic bradyarrhythmia secondary to risperidone. Am J Psychiatry 2003; 160 (12): 2243.
Hellerstedt B, Ahmed A. Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment. Ann Oncol 2003 Dec; 14 (12): 1792
King DS, Wilburn AJ, Wofford MR, et al. Cognitive impairment associated with atorvastatin and simvastatin. Pharmacotherapy 2003 Dec; 23 (12): 1663–7.
Shah P, Ramesh S. Desensitization of a patient with growth hormone hypersensitivity [abstract no. P155 plus poster]. Annual Meeting of the American College of Allergy, Asthma and Immunology; 2003 Nov 7–12; New Orleans, 62
Kuczkowski KM, Benumof JL. Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications. J Clin Anesth 2003; 15 (5): 357–8.
Umebayashi Y, Furuta J. Anaphylaxis due to tosufloxacin tosilate. J Dermatol 2003 Sep; 30 (9): 701–2
Belahcen A, Erreimi N, Benkirane R, et al. Secondary hyperparathyroidism caused by valproic acid and phenobarbital: a case report. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 207–8
Kastalli K, El A¿dli S, Daghfous R, et al. Nightmares induced by valsartan. Pharmacoepidemiol Drug Saf 2003 Oct; 12 Suppl. 2: 236
Ladas ID, Moschos MM, Rouvas AA, et al. Lacquer crack formation after photodynamic therapy. Eur J Ophthalmol 2003 Oct; 13 (8): 729–33.
Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ 2003 Dec 20; 327 (7429): 1454.
Privitera MR, Maharaj K. Mania from dose-related ziprasidone augmentation of an SSRI. J Clin Psychiatry 2003 Nov; 64 (11): 1393–4.
Licina M, Tavcar R. Facialis palsy attributable to depot antipsychotic therapy. Can J Psychiatry 2003 Nov; 48 (10): 712–3.
Rights and permissions
About this article
Cite this article
First reports of adverse drug reactions (ADRs) in recent weeks. Drugs Ther. Perspect 20, 21–22 (2004). https://doi.org/10.2165/00042310-200420030-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420030-00007